Dr. Molinari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 665
Rochester, NY 14642Phone+1 585-275-1733Fax+1 585-756-4726
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Orthopaedic Surgery Of The Spine, 1997 - 1998
- Icahn School of Medicine at Mount SinaiResidency, Orthopaedic Surgery, 1989 - 1993
- National Capital ConsortiumInternship, Transitional Year, 1988 - 1989
- Icahn School of Medicine at Mount SinaiClass of 1988
Certifications & Licensure
- NH State Medical License 2003 - Present
- NY State Medical License 1989 - 2026
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 54 citationsFusion versus nonoperative care for chronic low back pain: do psychological factors affect outcomes?Michael D. Daubs, Daniel C Norvell, Robert McGuire, Robert W. Molinari, Jeffrey T. Hermsmeyer
Spine. 2011-10-01 - 158 citationsProphylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year periodRobert W. Molinari, Oner A. Khera, William J. Molinari
European Spine Journal. 2012-06-01 - 14 citationsProximal Junctional Kyphosis: A Pediatric and Adult Spinal Deformity Surgery Dilemma.Aleksander P Mika, Addisu Mesfin, Paul T. Rubery, Robert W. Molinari, Khaled M. Kebaish
JBJS Reviews. 2019-04-01
Press Mentions
- Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington's Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug CandidateJuly 9th, 2018
- US FDA Allows Trial to Proceed for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)April 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: